Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
-
OptiMAL® R&D Update
31 January 2025
-
Approval of Grant Funding Application
04 December 2024 -
Half year Report
19 November 2024
Investor Alert
Sign up for Investor Alerts »